FDA Seeks Fines From Advanced Bionics And Execs For Not Filing Supplement
This article was originally published in The Gray Sheet
Executive Summary
FDA is pursuing Advanced Bionics and its two co-CEOs for $1.1 million each in fines, alleging that the company did not file a PMA supplement for adding a vendor for a component of its cochlear implant